Starbucks offers free coffee on Monday after Super Bowl 59 – how to get it

Yahoo06-02-2025

The Brief
Starbucks is offering free coffee to its rewards members on the Monday after the Super Bowl.
Customers can stop by a store to get a free tall (12-ounce) hot or iced brewed coffee at any time on Monday, Feb. 10.
The chain said customizations may cost extra.
SEATTLE - Super Bowl Sunday can sometimes lead to a long Monday, and Starbucks said it is offering a free coffee for that post-game day fatigue.
Fans can get their caffeine fix on Feb. 10 at U.S. locations. Here's what to know:
What we know
Starbucks Rewards members in the U.S. can stop by a store to get a free tall (12-ounce) hot or iced brewed coffee at any time on Monday, Feb. 10. The chain said Starbucks Reward members will see the "Starbucks Monday" coupon available in the app prior to placing a mobile order. Customers can also let the barista know they'd like to redeem their coupon when ordering in the store or in the drive-thru.
What you can do
Those who aren't Starbucks Rewards members can sign up by 11:50 p.m. PT on Feb. 9 to get the Starbucks Monday coupon in the app. Starbucks added that those who join on Feb. 10 can see a barista "in the store to enjoy a coffee on us."
The Fine Print
Starbucks said the offer excludes Nitro Cold Brew, Cold Brew, and Starbucks Reserve coffee. It also does not include delivery services, and customizations "may cost extra." The deal is limited to one free coffee per customer.
Big picture view
Many restaurant chains are getting into the Super Bowl spirit by offering similar deals and freebies. These include deals at Applebee's, Chipotle, and a contingent offer from Buffalo Wild Wings if the game goes into overtime. Chewy, the online pet retailer, is also giving away thousands of free treats if the Philadelphia Eagles ("the animal team") beat the Kansas City Chiefs.
Stream Super Bowl LIX live & free! Coming to you live from Caesars Superdome in New Orleans, Louisiana on Sunday, February 9, 2025. Tune in to pregame shows starting at 1 p.m. ET with the big game on at 6 p.m. ET. Stream Live & Free in 4K on Tubi or watch on FOX. (Must be signed in to watch.)
The Source
This story was reported using information published by Starbucks about its Feb. 10 promotion of free coffee. It was reported from Cincinnati.

Hashtags

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

2025 Boss Open: Fognini [117th] vs. Moutet [91st] Prediction, Odds and Match Preview

USA Today

28 minutes ago

USA Today

2025 Boss Open: Fognini [117th] vs. Moutet [91st] Prediction, Odds and Match Preview

2025 Boss Open: Fognini [117th] vs. Moutet [91st] Prediction, Odds and Match Preview Corentin Moutet (No. 91) will meet Fabio Fognini (No. 117) in the Round of 32 at the Boss Open on Tuesday, June 10. Moutet has -295 odds to earn a spot in the Round of 16 over Fognini (+220). Tennis odds courtesy of BetMGM Sportsbook. Odds updated Tuesday at 6:35 AM ET. For a full list of sports betting odds, access USA TODAY Sports Betting Scores Odds Hub. Fabio Fognini vs. Corentin Moutet matchup info Tournament: Boss Open Boss Open Round: Round of 32 Round of 32 Date: Tuesday, June 10 Tuesday, June 10 Court Surface: Grass Watch the Tennis Channel and more sports on Fubo! Fognini vs. Moutet Prediction Based on the implied probility from the moneyline, Fognini has a 74.7% to win. Fognini vs. Moutet Betting Odds Fognini vs. Moutet matchup performance & stats

Commanders' 'Best Offseason Move' Low-Hanging Fruit

Yahoo

40 minutes ago

Yahoo

Commanders' 'Best Offseason Move' Low-Hanging Fruit

Commanders' 'Best Offseason Move' Low-Hanging Fruit originally appeared on Athlon Sports. The Washington Commanders weren't the squashbuckling team that added a host of free agents and had over 10 draft picks this offseason, but that doesn't mean it wasn't productive. Advertisement In fact, one could argue that this offseason was better than the one 12 months ago. Granted, that is in the eye of the beholder, and the roster is in a different spot than a year ago. But with only two big moves made, with Deebo Samuel and Laremy Tunsil traded for to fill two key offensive positions, finding Washington's best piece of business isn't too hard. CBS Sports has landed on the trade for Samuel. "Is Samuel a durable game-breaker going on 30? Maybe," CBS Sports wrote. "Maybe not. Still, Washington added the former 49ers star for a single fifth-round pick. That's a potential steal given his fit as a rugged multipurpose weapon opposite the field-stretching Terry McLaurin. It's just nice to see this team isn't sitting on its hands with the dynamic Jayden Daniels under center." Washington, District of Columbia, USA; Washington Commanders wide receiver Deebo Samuels (L) and Commanders quarterback Jayden Daniels (R) wave to the crowd from courts wide during the game between the Washington Mystics and Atlanta Dream at CareFirst Arena. Geoff Burke-Imagn Images What Deebo could do for an offense that was equally as dangerous running or passing the football last season is tantalizing. Advertisement As a runner, Samuel can be the power-packed weapon who can pick up tough yards, but also break the odd 20+ yard run. As a receiver, his YAC ability is something that causes defensive coordinators to have sleepless nights due to his tough running style and ability to stand up in tackles and fall forward for extra yards, a notable feature. Yes, Tunsil will protect Daniels better than Brandon Coleman, but Deebo will be where all the eyes are in 2025 as he could be the lightning rod that propels this team to Super Bowl glory. Related: Commanders Predicted To Trade Terry McLaurin To AFC South Team Related: Commanders' Dan Quinn Congratulates Fellow D.C. Award Winner This story was originally reported by Athlon Sports on Jun 10, 2025, where it first appeared.

Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th

Yahoo

44 minutes ago

Yahoo

Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at HENDERSON, Nev., June 10, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB:NIKA), based in Colorado, focused on cures for life-threatening diseases, today announced that Dimitar Savov, CEO, will present live at the Life Sciences Virtual Investor Frum hosted by on June 11th, 2025 DATE: June 11th TIME: 1:00 PM ETLINK: REGISTER HEREAvailable for 1x1 meetings: June 12th-17th between 09:00am ET and 11:30am ET This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at Recent Company Highlights On May 19, 2025, NIKA published a market analysis for the countries of Ukraine, Syria, Jordan, Iraq, UAE, where NIKA has exclusive distribution agreements and has estimated a total of around €656 million in potential revenue. NIKA's partner company, Nika Europe, has made the second $195,554 payment for the vial production line and is currently finalizing the details of the clean rooms design in order to start construction. The production facility is expected to be completed in H2, 2025. On April 11, 2025, Nika Pharmaceuticals, Inc. published a report on the therapeutic effect and potential economic impact of ITV-1, which can be found here. On July 11, 2024 Nika Pharmaceuticals, Inc. signed an exclusive distribution agreement for the Republic of Nigeria. Under the terms, NIKA will receive €1,980 per each set of ITV-1 with two sets necessary for each treatment, which could result in €7.9 billion revenue. About Nika Pharmaceuticals, Inc. Nika Pharmaceuticals, Inc. (NIKA) is a pharmaceutical company, specializing in the treatment of HIV/AIDS, Hepatitis B and C, Rheumatoid Arthritis, Cancer, Diabetes, and all diseases, for which strengthened cell immunity is of vital importance. NIKA's intellectual property includes six drugs in injection form – two of which have successfully undergone clinical trials with good treatment results – four drugs in tablet form, and eleven dietary supplements. NIKA's goal is to not only achieve corporate profits, but to provide better and easier access to life-saving medicinal drugs and useful dietary supplements. Find more on Forward-looking Statement: This press release contains forward-looking statements. Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are 'forward- looking statements.' These forward-looking statements generally are identified by the words 'believes,' 'expects,' 'anticipates,'' estimates,' 'intends,' 'strategy,' 'plan,' 'may,' 'will,' 'would,' 'will be,' 'will continue,' 'will likely result,' and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. CONTACTS:Nika Pharmaceuticals, Clifford P. RedekopTitle Corporate SecretaryPhone (702) 326-3615 Email cliffredekop@ Virtual Investor Conferences John M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data